Ganes C. Sen,  Ph.D.

Ganes C. Sen, Ph.D.

Staff

The Thomas Lord Endowed Chair in Molecular Biology

Interim Chair

Lerner Research Institute, 9500 Euclid Avenue, Cleveland, Ohio 44195
Location: NE4-314
Email: seng@ccf.org
Phone: (216) 444-0636
Fax: (216) 444-9329

 


My research interest is in understanding how mammals respond to virus infection, both at the cellular level and at the organism level. The interferon (IFN) system plays a major role in shaping the innate immune antiviral response and a focus of our research is on the analysis of the mechanism of IFN induction by virus infection; we are deciphering the signaling mechanism of Toll like receptors, the RIG-I-like helicase receptors and the cytoplasmic DNA-sensing cGAS/STING receptor, which are activated by viruses. We uncovered an unexpected link between innate immunity and growth factor receptors by our observation that the EGF receptor is essential for many of these signaling pathways. Another focus of our research is on understanding the mode of antiviral actions of a set of IFN-induced proteins, called IFITs. Recently we have generated several mouse strains in which one or more IFIT genes have been knocked-out. Challenging these genetically modified mice with different viruses has revealed interesting and unexpected facets of IFN-action. It appears that a specific IFN-induced protein can inhibit the replication of only a limited set of viruses in a specific cell type. Thus, Ifit2, but not Ifit1, can inhibit the replication of vesicular stomatitis virus in neurons but not in other cell types. Another study has revealed that IRF-3, a transcription factor responsible for inducing IFN synthesis, has an unrelated second function. Upon activation by virus infection, it triggers apoptosis by transporting the pro-apoptotic protein, Bax, to mitochondria. The apoptotic action of IRF-3, in addition to its transcriptional action, protects mice from viral pathogenesis.

In other words ...

Many components of our immune system protect us from microbial infection; among them is the interferon system, the primary line of defense against viruses. Virus infection is often self limiting because it triggers the synthesis of many antiviral proteins, including interferon, which ultimately inhibit virus replication. We want to understand how cells sense virus infection, how this sensing leads to induced synthesis of the antiviral proteins and how specific members of this family of protein protect us from specific viruses.


Daffis S, et al. 2’-O Methylation of the viral mRNA cap evades host restriction by IFIT family members. 2010. Nature. 468: 452-456. PMCID: PMC3058805.

Fensterl V, et al. Interferon-induced Ifit2/ISG54 Protects Mice from Lethal VSV Neuropathogenesis. 2012. PLoS Pathog. 8: e1002712. PMCID: PMC3355090.

Yamashita M, et al. Epidermal growth factor receptor is essential for toll-like receptor 3 signaling. 2012. Sci. Signal. 5, ra50. PMCID: PMC3431157.

Wang, X., T. Majumdar, P. Kessler, E. Ozhegov, Y. Zhang, S. Chattopadhyay, S. Barik and G.C. Sen. 2016. STING requires the adaptor TRIF to trigger innate immune responses to microbial infection. Cell Host Microbe. 20(3):329-41. PMCID: PMC5026396.

Chattopadhyay, S., T. Kuzmanovic, Y. Zhang, J.L. Wetzel and G.C. Sen. 2016. Ubiquitination of the transcription factor IRF-3 activates RIPA, the apoptotic pathway that protects mice from viral pathogenesis. Immunity. 44(5):1151-61. PMCID: PMC4991351. 


11/15/2017 |  

A Lifetime of Achievement; Dr. Sen Honored

Ganes C. Sen, PhD, of the Department of Immunology, Lerner Research Institute, received the prestigious Honorary Lifetime Membership Award from the International Cytokine and Interferon Society at its November "Cytokines 2017" conference in Kanazawa, Japan. Dr. Sen was honored for his contributions to the field of interferon research. Interferons are proteins that are made and released by host cells in response to the presence of harmful foreign pathogens. His work has greatly expanded the scientific community's understanding of how they contribute to immune and antiviral responses.